Disclosure 0000907654-26-000104-1

SEC FORM 4

$195,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 25,000 shares at $7.8 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0000907654-26-000104 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-10-02. https://desqlong.com/cards/0000907654-26-000104-1 (retrieved 2026-10-03).